WSJ Pro: Venture Capital publishes article about Immuneering Corporation

IMMUNEERING RAISES $20 MILLION FOR NEW DRUG-DISCOVERY EFFORT

Company formed in 2008 also provides services to pharmaceutical companies

 

By Brian Gormley

 

Venture capitalists are betting $20 million that technology from Immuneering Corp. will enable it to develop medicines aimed at molecular targets that have long tantalized and eluded drugmakers.